Asia Fresh News

Asia Fresh Stories

Archive for April 23rd, 2013

Frost & Sullivan Company of the Year Award Conferred on Medtech SAS

leave a comment »

LONDON, April 22, 2013 /PRNewswire/ — Based on its recent analysis of the surgical robotics for neurosurgical interventions market, Frost & Sullivan recognises Medtech SAS with the prestigious 2013 European Company of the Year Award.

Medtech SAS is commended for its innovative ROSA™ system, which successfully addresses the need for an accurate, economical and clinically effective solution for patients requiring neurological interventions.

“As a robotic surgery system, ROSA™ performs the function of a surgical assistant for neurosurgical procedures,” notes Frost & Sullivan Healthcare Industry Analyst Beulah Devadason. “The integration of all neurosurgical requirements and the broad range of procedures that can be performed using ROSA™ make it a true technological innovation in the field of neurosurgery.”

Preoperative planning, surgical navigation and integration of intraoperative imaging are necessary to ensure a high degree of safety and accuracy in neurosurgery. ROSA™ is perfectly designed to integrate all these important surgical steps but also to incorporate very precise instrument manipulation.

ROSA™ enables open-skull, stereotactic and NeuroEndoscopic surgeries. The combination of planning, navigation and instrument manipulation that facilitates shorter surgery times is coupled with minimally invasive interventions in a fully frameless environment.

The shortening of procedure times, which may be up to 50 per cent for certain indications, enables tangible cost savings through simplified workflow, shorter operating room time and reduced surgeon workload, thus allowing multiple procedures within the same day. This further enhances the return on investment for hospitals.

“From a patient perspective, ROSA™ supports reduced trauma by doing away with stereotactic frames as well as enabling minimally-invasive interventions for procedures that traditionally required open-skull surgeries,” states Devadason. “Therefore, Medtech SAS’s ROSA provides superior customer value in robotic neurosurgery.”

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in growth strategy and implementation, degree of innovation in technology and products, and leadership in customer value.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Medtech SAS

The primary motivation that inspired Bertin Nahum to launch Medtech in July 2002 was to benefit patients while developing robots capable of assisting surgeons with their difficult tasks.

His prior experience within several major medical robotic companies and his pioneering spirit were pivotal to the development of the latest technology in robotic-assisted neurosurgery.

In 2006, Medtech received notice on the International scene with Zimmer’s acquisition of their patent portfolio of BRIGIT™, Medtech’s first surgical robotic endeavour. Zimmer Inc. is a leading American company in the field of Orthopaedic Surgery and is consequently widely recognized throughout the world.

Medtech’s team subsequently designed ROSA™, a new generation of Robotic Surgical assistant dedicated to the field of Neurosurgery. In 2009, ROSA™ received market approval in Europe with the CE Mark as well as FDA approval in the USA and Health Canada Homologation in Canada. Now in place, it works alongside leading neurosurgeons in several hospitals within Europe, North America and Asia.

Headquartered in Montpellier, France, with offices in New York and Canada as well as sales transactions conducted through a dozen distributors worldwide, Medtech has developed an International reach with a presence in about thirty countries.

Today, Medtech has gained a significant position as a key player in the medical robotics field due to constant and dynamic innovations since the company’s inception. The company is extending its leadership to other areas of surgery with new products currently under development.

Contact us:

Follow us on:!/MedtechSurgical

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion
Join Us:           Join our community
Subscribe:       Newsletter on “the next big thing”
Register:         Gain access to visionary innovation


Sophie Munoz-Vincent
Sales Manager
Medtech SAS
T: +33 (0)4 67 10 77 40

Kristina Menzefricke
Best Practices Group
Frost & Sullivan
T: +44 (0) 207 9157862

Source: Frost & Sullivan

Written by asiafreshnews

April 23, 2013 at 10:43 pm

Posted in Uncategorized

TriReme Receives Shonin Approval to Market Glider(TM) PTCA Catheter

leave a comment »

PLEASANTON, Calif. and SINGAPORE, April 22, 2013 /PRNewswire/ — TriReme Medical, Inc. and its affiliates (TriReme) announced today that its Japanese partner, Century Medical, Inc. (CMI), has received Shonin approval for the Glider™ PTCA catheter indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion. Combining a skived tip and a unique braided shaft, Glider™ is the world’s only torqueable PTCA catheter and is designed to assist physicians in treating the most challenging cases such as bifurcations and highly stenosed lesions.

“We are proud to receive this regulatory approval for our highly differentiated Glider™ PTCA catheter,” stated Eitan Konstantino PhD, CEO and President of TriReme. “We are looking forward to working closely with our partner, CMI. This milestone represents yet another concrete step in our strategic focus on the important Asian markets.”

“Japanese cardiologists are well known for treating the most complex vascular disease,” explained Akira Hoshino, President and CEO of CMI. “With its unique technology, Glider™ is designed to cross through tight lesions and provide improved outcomes where other balloons are challenged. Glider™ represents the first product, with others to follow, in our strategic partnership that will allow us to bring TriReme’s cutting edge and high quality devices to Japan.”

About TriReme Medical, Inc.

Based in Singapore and Pleasanton, California, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets. TriReme has recently announced a strategic partnership with Weigao, one of China best known medical device companies.

About Century Medical

Based in Tokyo, Japan, Century Medical, Inc. is a $140 million subsidiary company of ITOCHU Corporation (TSE: ITC) a $115 billion international trading company. Century Medical, Inc., with approx. 300 employees, has a 38 year experience specializing in the importation, sale and marketing of advanced single use and implantable medical devices.

Source: TriReme Medical, Inc.

Written by asiafreshnews

April 23, 2013 at 5:33 pm

Posted in Uncategorized

Asian Innovators To Unveil Industry Driving News At Global Video Game Show

leave a comment »




— Asian Companies to Show Strong Presence at E3 2013

WASHINGTON, April 22, 2013 /PRNewswire/ —

WHAT: The future of video games will be unveiled in large part by a throng of pioneering Asian companies planning to make a significant showing at E3, the world’s premier trade show for computer and video games. Asian video game companies and their US counterparts will be closely followed by industry watchers as they make some of the biggest news announcements impacting the upcoming holiday season and into 2014. Featured Asian exhibitors have roots across Japan, China, Korea, and Vietnam including:

  • Beijing Pixel Software
  • Capcom
  • Hong Kong Trade Development Council
  • Konami
  • MAG II Gun
  • Natsume
  • Nintendo
  • Nyko
  • Square Enix
  • Sony Computer Entertainment
  • Tecmo Koei
  • Virtuos
  • XSEED Games

E3 highlights include:

  • 45,000 video game industry professionals, investor analysts, journalists and retailers from more than 100 countries expected to attend
  • Hundreds of title announcements for game consoles, PCs, mobile phones and handheld devices
  • Live show floor demos
  • Spotlight on social and mobile innovations
  • Press conferences from major publishers including Nintendo of America and Sony Computer Entertainment America among others
  • Top entertainment industry celebrity and executive attendance

WHEN: Tuesday, June 11 – Thursday, June 13, 2013

Tuesday, June 11: Noon – 6:00 pm
Wednesday, June 12: 10:00 am – 6:00 pm
Thursday, June 13: 10:00 am – 5:00 pm

WHERE: Los Angeles Convention Center, Los Angeles CA

ADMISSION: Registration is free to approved media

HOW TO REGISTER: Journalists seeking credentials should apply at

CONTACT INFO: The E3 Media Team at

E3 Expo is a trade-only event and is not open to the public. No one under the age of 17 is permitted.




Source: Entertainment Software Association

Written by asiafreshnews

April 23, 2013 at 4:19 pm

Posted in Technology

UBM Asia and RESTEC Enter Into a Strategic Partnership on Jewellery Fairs in Russia

leave a comment »

HONG KONG, April 22, 2013 /PRNewswire/ — UBM Asia today announces that it has entered into a strategic partnership with RESTEC Group on the leading B2B jewellery fairs in Russia.

The partnership will start with the 2014 editions of the following fairs by RESTEC:

(Month) Venue Exhibitors / Visitors
in the past edition
Junwex St. Petersburg
(Februrary) Lenexpo Exhibition Complex,
St. Petersburg 639 / 40,130
Junwex New Russian Style
(May) All-Russian Exhibition Centre WC, Moscow 559 / 28,559
Junwex Moscow
(September) All-Russian Exhibition Centre WC, Moscow 715 / 39,347

Established in 1990, RESTEC is now one of the top three leading organisers in Russia with over 100 events in Russia and abroad for a wide range of industries. Junwex St. Petersburg is the longest-standing jewellery fair held since 1993 and even Junwex Moscow, the youngest among these three Junwex exhibitions, will be having its 9th edition this year.

UBM Asia is the leading exhibition organiser in Asia with 1,200 staff in over 30 offices across Asia and in the USA. It organises the world’s number one fine jewellery event — the September Hong Kong Jewellery & Gem Fair, and 20 other renowned jewellery fairs held in Mainland China, India, Japan, Turkey, Taiwan, Singapore and Germany. It also publishes magazines and operates websites for the world’s jewellery industry.

Serguei Trofimov, President of RESTEC Group said: “Our jewellery events are well-established as the leading events of its kind in Russia. We look forward to a very successful partnership with UBM Asia in getting more international exhibitors and visitors to the events.”

Jime Essink, President & Chief Executive Officer of UBM Asia said: “RESTEC is the leader of jewellery exhibitions in Russia. We are very excited to partner with RESTEC in facilitating the global jewellery industry to extend further to the flourishing Russia market with our strong office network and extensive connection with the jewellery trade. Also, with RESTEC representing UBM Asia in Russia for our jewellery fairs, we are set to welcome more Russian buyers and exhibitors to our events.”

Notes to Editors

1. About UBM Asia (
Owned by UBM plc listed on the London Stock Exchange, UBM Asia is Asia’s leading exhibition organiser and the biggest commercial organiser in mainland China, India and Malaysia. Established with its headquarters in Hong Kong and subsidiary companies across Asia and in the US, UBM Asia has a strong global presence in 25 major cities with 29 offices and over 1,200 staff.

With a track record spanning over 30 years, UBM Asia operates in 19 market sectors with 160 dynamic face-to-face exhibitions, 75 high-level professional conferences, 28 targeted trade publications, 18 round-the-clock vertical portals and virtual event services for over 1,000,000 quality exhibitors, visitors, conference delegates, advertisers and subscribers from all over the world. We provide a one-stop diversified global service for high-value business matching, quality market news and online trading networks.

UBM Asia has extensive office networks in China, Southeast Asia and India, three of the world’s fastest growing B2B events markets. UBM China has 11 offices in the major cities in mainland China, including Beijing, Shanghai, Guangzhou, Hangzhou, Chengdu and Shenzhen, where we organise more than 60 exhibitions and conferences. In ASEAN, UBM Asia operates from its offices in Malaysia, Thailand, Indonesia, Singapore, Vietnam and the Philippines with over 50 events in this region. UBM India teams in Mumbai, New Delhi, Bangalore, Chennai and Hyderabad organise 20 exhibitions and 60 conferences every year across the country.

2. About UBM plc (
UBM plc is a leading global business media company. We inform markets and bring the world’s buyers and sellers together at events, online, in print and provide them with the information they need to do business successfully. Our 6,500 staff in more than 30 countries are organised into specialist teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.

For more information, go to; follow us on Twitter at @UBM_plc to get the latest UBM news.

3. About RESTEC (
RESTEC® Exhibition Company is one of the top three leaders of Russia’s exhibition business. The optimal structure formed by RESTEC® lets us combine exhibition, congress, business and contest programs that altogether foster effective work of our exhibitors, participants, delegates and trade visitors. At this point our exhibition and congress events continue developing as centers of international business networking with the constantly growing number of countries and participants represented.

For press enquiries, please contact:
Jennifer Law, Director of Corporate Marketing & Communications, UBM Asia
Tel: +852-2516-1691
Fax: +852-3749-7342

Written by asiafreshnews

April 23, 2013 at 3:16 pm

Posted in Uncategorized

Geely Launch KC Concept at the 2013 Shanghai Auto Show

leave a comment »

SHANGHAI, April 22, 2013 /PRNewswire/ — At 2013 Shanghai Auto Show Geely continued to push its range of market leading technologies and internationally applauded car models with new model updates and the launch of a new concept model that showcases Geely’s advanced research and design capabilities.

Geely Launch KC Concept at the 2013 Shanghai Auto Show
Geely Launch KC Concept at the 2013 Shanghai Auto Show

The KC concept is a fastback based sedan with its total length reaching 4690mm and a wheelbase of 2880mm. The exterior design borrows heavily from classical Chinese history points, from the front observers will note the strong shoulder lines that flow over the front wheel arch to give a sense of speed and elegance whilst the wide stance gives a feeling of strength and confidence in the vehicle. The KC makes use of daylight running lights to further enhance the strong lines, the headlights and grill combine to form a unified graphic which gives the impression of distinctive stone bridges which feature heavily in classical Chinese art. The fog lamps also take design cues from classical Chinese art, with them being similar in style to Chinese ornamentation to give a functional and aesthetic appeal.

The interior continues to reflect on traditional Chinese artwork with its refined and elegant dashboard that are intersected by the instrument panel, arching the style of a traditional stone bridge. The instrument panel, steering wheel and door arm rests merge into one as if there were a curling book page giving a light and airy atmosphere in the cabin with the central console arching back into the rear passenger area. The seating area radiates an elegant, relaxing mood whilst floating on bridge like supports whilst the material again looks back to traditional Chinese styling with asymmetric overlapping folds. Geely’s design team have looked towards luxury materials such as jade, fine red wood and ambient lighting to increase the sense of interior quality, with overly contrasting warm-white and traditional dark red Chinese elements to create a dignified atmosphere in both the front and rear of the concept model to give a clean and clear interior appearance.

The KC Concept is a product of the the first joint project by Geely’s recently appointed Vice President of Design Mr. Peter Horbury and Design Director Mr. Ken Ma, both designers are veterans of the global automotive industry and will continue to work together to develop world class cars for the Geely brands.

Source: Zhejiang Geely Holding Group

Written by asiafreshnews

April 23, 2013 at 12:42 pm

Sunshine Oilsands Ltd.: Update on West Ells Project Capital Cost Estimate and Construction Schedule

leave a comment »

This is an announcement made pursuant to the Inside Information Provisions under Part XIVA of the Securities and Futures Ordinance (Cap. 571) and Rule 13.09 of the Rules Governing the Listing of Securities on the Stock Exchange.
HONG KONG /PRNewswire/ — Sunshine Oilsands Ltd. (“Sunshine”) (HKEX: 2012; TSX: SUO) has undertaken a detailed review of its cost estimate and schedule for the West Ells SAGD Project, currently under construction near Ft. McMurray, Alberta. The installed cost for the Project was previously estimated at approximately $468 million, excluding contingencies and $30 million for the shared, multi-project main access road, with first steam scheduled for the third quarter of 2013.
While good progress and important milestones have been achieved on the Project, several factors have contributed to an assessment that the West Ells project will see minor delays and higher costs. Sunshine now expects Phase 1 first steam to be injected in late Q3 or early Q4.
Total (Phase 1 and 2) direct costs at West Ells are now estimated at approximately $496 million, excluding the road and further contingencies. This new figure is based on our revised cost and presentation format, with certain expenditure items now allocated out to other areas of investment or cost categories.
The Project’s current status for selected areas of activity is summarized as:
Drilling of the first eight well pairs for the 5,000 bpd Phase 1 is now complete, with well completions underway. The drilling rig will now move to the second well pad required for the additional 5,000 bpd Phase 2, scheduled to be brought on line in the first quarter of 2014.
Approximately 75% of the piles have been set for Phase 1, with Phase 1 piling expected to be completed by the end of May.
Module procurement is well underway, with 5 modules completed and the balance of Phase 1 modules under construction.
Field constructed storage tanks are 60% complete.
About 80% of the operations team has been hired and is expected to move to the site over the next two months to assist with facility turnover, commissioning and start up.
With the currently anticipated cost increases, and after allowing for expenditures for costs and investments in other categories of activity, Sunshine forecasts its 2013 overall capital needs to grow by approximately $30 million. This estimate assumes certain investments relating to development of future projects will be deferred if necessary. Overall funding for 2013 and 2014 will continue to come from a combination of cash on hand, borrowing, and potential joint ventures, as well as revenue from early stage production from West Ells in 2014. Sunshine intends to use the Company’s revolving credit facility of up to $200 million as a source of funding, with availability and size subject to meeting certain tests. Sunshine has notified its lending group of the increased capital cost at West Ells. The Company continues to monitor markets to optimize its sources of funding.
Sunshine Oilsands Ltd. is one of the largest non-partnered holders of oil sands leases by area in the Athabasca oil sands region, which is located in the province of Alberta, Canada. Since the Company’s incorporation on 22 February 2007, Sunshine has secured over one million acres of oil sands leases (equal to approximately 7% of all granted leases in this area).
The Company’s principal operations are the exploration, development and production of its diverse portfolio of oil sands leases. Its principal operating regions in the Athabasca area are at West Ells, Thickwood, Legend Lake, Harper, Muskwa, Goffer, Pelican and Portage. Sunshine’s oil sands leases are grouped into three main asset categories: clastics, carbonates and conventional heavy oil.
This announcement may contain forward-looking information that is subject to various risks, uncertainties and other factors. All statements other than statements and information of historical fact are forward-looking statements. The use of any words “estimate”, “forecast”, “expect”, “project”, “plan”, “target”, “vision”, “goal”, “outlook”, “may”, “will”, “should”, “believe”, “intend”, “anticipate”, “potential”, and similar expressions are intended to identify forward-looking statements. Forward-looking statements are based on Sunshine’s experience, current beliefs, assumptions, information and perception of historical trends available to Sunshine, and are subject to a variety of risks and uncertainties including, but not limited to those associated with resource definition and expected reserves and contingent and prospective resources estimates, unanticipated costs and expenses, regulatory approval, fluctuating oil and gas prices, expected future production, the ability to access sufficient capital to finance future development and credit risks, changes in Alberta’s regulatory framework, including changes to regulatory approval process and land-use designations, royalty, tax, environmental, greenhouse gas, carbon and other laws or regulations and the impact thereof and the costs associated with compliance. Although Sunshine believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned that the assumptions and factors discussed in this information release are not exhaustive and readers are not to place undue reliance on forward-looking statements as our actual results may differ materially from those expressed or implied. Sunshine disclaims any intention or obligation to update or revise any forward-looking statements as a result of new information, future events or otherwise, subsequent to the date of this announcement, except as required under applicable securities legislation. The forward-looking statements speak only as of the date of this announcement and are expressly qualified by these cautionary statements. Readers are cautioned that the foregoing lists are not exhaustive and are made as at the date hereof. For a full discussion of our material risk factors, see “Risk Factors” in our most recent Annual Information Form, “Risk Management” in our current MD&A and risk factors described in other documents we file from time to time with securities regulatory authorities, all of which are available on the Hong Kong Stock Exchange at, on the SEDAR website at or our website at
This document does not constitute and is not an offer to sell or a solicitation of an offer to buy common shares of the Company in the United States (including its territories and possessions, any State of the United States and the District of Columbia) or elsewhere.
Source: Sunshine Oilsands Ltd.
Related stocks: HongKong:2012 Toronto:SUO

Written by asiafreshnews

April 23, 2013 at 12:26 pm

Posted in Uncategorized